<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The research was aimed to detect the expression levels of <z:hpo ids='HP_0009919'>retinoblastoma</z:hpo> protein (pRb) in child <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> cells, and to explore its possible association with <z:hpo ids='HP_0001909'>leukemia</z:hpo> cells cycle, the risk of <z:e sem="disease" ids="C0242596" disease_type="Neoplastic Process" abbrv="MRD">disease, minimal residual</z:e> disease (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MRD</z:e>) monitoring and prognosis of <z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Flow cytometry (FCM) was used to detect the expression of pRb in 89 cases of <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> (including 25 AML, 10 T-ALL and 54 B-ALL) and bone marrows from 7 <z:mpath ids='MPATH_458'>normal</z:mpath> children (control group) </plain></SENT>
<SENT sid="2" pm="."><plain>Meanwhile the cell cycle in some cases was analyzed </plain></SENT>
<SENT sid="3" pm="."><plain>The results showed that (1) the FCM could accurately detect the expression of pRb in <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> cells; (2) the high level of pRb expression was frequent in <z:hpo ids='HP_0000001'>all</z:hpo> types of child <z:hpo ids='HP_0002488'>acute leukemias</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>In the same case, the expression of pRb was significantly increased in <z:hpo ids='HP_0001909'>leukemia</z:hpo> cells when compared with non-<z:hpo ids='HP_0001909'>leukemia</z:hpo> cells </plain></SENT>
<SENT sid="5" pm="."><plain>And no detectable pRb protein was found in partial cases of <z:hpo ids='HP_0002488'>acute leukemia</z:hpo>; (3) there was a close relation between expression of pRb and the cell cycle of <z:hpo ids='HP_0001909'>leukemia</z:hpo> cells, the number of G(1) phase cells in pRb positive case of <z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e> was more than that in pRb negative case (92% vs 77%); (4) in <z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e>, the level of pRb expression in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MRD</z:e> positive group was significantly lower than that in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MRD</z:e> negative group (P &lt; 0.05), but pRb expression was stable in non-<z:hpo ids='HP_0001909'>leukemia</z:hpo> cells during therapy; (5) pRb expression was related to the early response to therapy in <z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e>, the expression of pRb was significantly increased in sensitive group when compared with insensitive group (P &lt; 0.05) </plain></SENT>
<SENT sid="6" pm="."><plain>It is concluded that high level or absence of pRb expression can be found in child <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> cells </plain></SENT>
<SENT sid="7" pm="."><plain>The expression of pRb is positively related to cell cycle of <z:hpo ids='HP_0001909'>leukemia</z:hpo> cells, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MRD</z:e> monitoring and the early response to therapy </plain></SENT>
<SENT sid="8" pm="."><plain>In short, the detection of pRb expression level can guide the therapy and the evaluation of prognosis in <z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e> </plain></SENT>
</text></document>